These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19473359)

  • 21. [Two siblings with adult-onset sialidosis type I (cherry-red spot-myoclonus syndrome)].
    Tana T; Komine Y; Kanzato N; Kawazoe N; Fukiyama K
    Rinsho Shinkeigaku; 1995 Jul; 35(7):803-5. PubMed ID: 8777807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sialidosis type 1: cherry red spot-myoclonus syndrome with sialidase deficiency and altered electrophoretic mobilities of some enzymes known to be glycoproteins. 1. Clinical findings.
    Thomas PK; Abrams JD; Swallow D; Stewart G
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):873-80. PubMed ID: 512662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of severe action myoclonus in sialidoses.
    Canafoglia L; Franceschetti S; Uziel G; Ciano C; Scaioli V; Guerrini R; Visani E; Panzica F
    Epilepsy Res; 2011 Mar; 94(1-2):86-93. PubMed ID: 21330109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex.
    Lukong KE; Landry K; Elsliger MA; Chang Y; Lefrancois S; Morales CR; Pshezhetsky AV
    J Biol Chem; 2001 May; 276(20):17286-90. PubMed ID: 11279074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sialidoses.
    Franceschetti S; Canafoglia L
    Epileptic Disord; 2016 Sep; 18(S2):89-93. PubMed ID: 27621198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucolipidosis I--a sialidosis.
    Sphranger J; Gehler J; Cantz M
    Am J Med Genet; 1977; 1(1):21-9. PubMed ID: 610423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A new observation of cherry-red spot myoclonus syndrome (author's transl)].
    Martin JJ
    Acta Neurol Belg; 1980; 80(1):30-6. PubMed ID: 7361541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fundus autofluorescence and optical coherence tomography of a macular cherry-red spot in a case report of sialidosis.
    Zou W; Wang X; Tian G
    BMC Ophthalmol; 2016 Mar; 16():30. PubMed ID: 27004518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and genetic characteristics of type I sialidosis patients in mainland China.
    Lv RJ; Li TR; Zhang YD; Shao XQ; Wang Q; Jin LR
    Ann Clin Transl Neurol; 2020 Jun; 7(6):911-923. PubMed ID: 32472645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral neuropathy in the cherry-red spot-myoclonus syndrome (sialidosis type I).
    Steinman L; Tharp BR; Dorfman LJ; Forno LS; Sogg RL; Kelts KA; O'Brien JS
    Ann Neurol; 1980 May; 7(5):450-6. PubMed ID: 6249183
    [No Abstract]   [Full Text] [Related]  

  • 31. Abnormal pattern electroretinograms with macular cherry-red spots: evidence for selective ganglion cell damage.
    Kirkham TH; Coupland SG
    Curr Eye Res; 1981; 1(6):367-72. PubMed ID: 7307543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase activity in the mucolipidoses (types I, II and III) and the cherry-red spot myoclonus syndrome.
    Potier M; Beauregard G; Bélisle M; Mameli L; Hong VN; Melançon SB; Dallaire L
    Clin Chim Acta; 1979 Dec; 99(2):97-105. PubMed ID: 574433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodality evoked potentials and EEG in a case of cherry red spot-myoclonus syndrome and alpha-neuraminidase deficiency (sialidosis type 1).
    Louboutin JP; Nogues B; Caillaud C; Elie B
    Eur Neurol; 1995; 35(3):175-7. PubMed ID: 7628501
    [No Abstract]   [Full Text] [Related]  

  • 34. Electrophysiological studies of myoclonus in sialidosis type 2.
    Tobimatsu S; Fukui R; Shibasaki H; Kato M; Kuroiwa Y
    Electroencephalogr Clin Neurophysiol; 1985 Jan; 60(1):16-22. PubMed ID: 2578348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis.
    Bonten EJ; Arts WF; Beck M; Covanis A; Donati MA; Parini R; Zammarchi E; d'Azzo A
    Hum Mol Genet; 2000 Nov; 9(18):2715-25. PubMed ID: 11063730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient.
    Penzel R; Uhl J; Kopitz J; Beck M; Otto HF; Cantz M
    FEBS Lett; 2001 Jul; 501(2-3):135-8. PubMed ID: 11470272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression.
    Pattison S; Pankarican M; Rupar CA; Graham FL; Igdoura SA
    Hum Mutat; 2004 Jan; 23(1):32-9. PubMed ID: 14695530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infantile sialidosis: natural history in a preterm infant with two new pathogenic mutations and new ocular findings.
    Pérez-Cabeza MI; Borrás F; Moreno-Medinilla EE; Bardán-Rebollar D; Ferrer-López I; Rodríguez-García E; Jiménez-Machado R; Castro-Vega I; Benito C; Escudero J; Yahyaoui R
    J AAPOS; 2019 Apr; 23(2):102-104. PubMed ID: 30445145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymes.
    Itoh K; Naganawa Y; Matsuzawa F; Aikawa S; Doi H; Sasagasako N; Yamada T; Kira J; Kobayashi T; Pshezhetsky AV; Sakuraba H
    J Hum Genet; 2002; 47(1):29-37. PubMed ID: 11829139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sialidosis type I (cherry red spot-myoclonus syndrome).
    Ganguly S; Gabani RU; Chakraborty S; Ganguly SB
    J Indian Med Assoc; 2004 Mar; 102(3):174-5. PubMed ID: 15473282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.